RARE DISEASERESEARCH ATLAS
Open navigation menu

ORPHA:168940

Chronic eosinophilic leukemia

low confidenceDisorder

Publications

2,235

Trials

44

Interventional, condition-specific

Researchers

1,250

Distinct authors in sample

Gene link

—

Readiness

3/6

Stages with a signal

Clinical definition (Orphanet)

A rare myeloproliferative neoplasm characterized by a clonal proliferation of eosinophilic precursors with persistent increase of eosinophils in peripheral blood and bone marrow, accompanied by increased blasts (<20%) or clonal cytogenetic or molecular genetic abnormalities. Cases with BCR-ABL1, PCM1-JAK2, ETV6-JAK2, or BCR-JAK2 fusion, or rearrangement of PDGFRA, PDGFRB, or FGFR1, are not included in this entity. Infiltration of the liver and spleen, as well as a variety of other organs, is typical. Patients may present with constitutional symptoms and signs and symptoms of organ involvement, such as endomyocardial fibrosis, peripheral , central nervous system manifestations, respiratory symptoms, or rheumatological findings. Acute transformation is common.

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Additional Mondo synonyms (6)

CEL · CEL/hypereosinophilic syndrome · chronic eosinophilic leukemia · chronic eosinophilic leukemia/hypereosinophilic syndrome · eosinophilic leukaemia · eosinophilic leukemia

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

3/6 stages with a signal

An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.

  1. Gene identifiedNot found

    No GenCC disease–gene assertion in this build

  2. LiteraturePresent

    2,235 matched papers (1,012 in last 10 years) Source

  3. Phenotype characterisedNot found

    No HPO disease–phenotype associations via Monarch for these Mondo IDs

  4. Animal modelNot found

    No Alliance genotype “model of” associations via Monarch for these Mondo IDs

  5. Orphan designationPartial

    1 FDA designation (none yet with FDA orphan-indication approval) — e.g. Imatinib mesylate Source

  6. Interventional trialPresent

    44 matched on ClinicalTrials.gov (2 recruiting in sample)

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Not yet — the cause hasn't been pinned down in GenCC.

No strong gene–disease assertion joined for this Orphanet entity.

Phenotypes (Monarch / HPO)

None returned for this Mondo ID. That often means “not linked under this ID,” not “no clinical features.”

Animal models (Monarch / Alliance)

None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.

Monarch fetch 2026-07-29

Therapies

Designations, candidates, and chemicals

FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.

Orphan designation (FDA · EMA)

1

Designation · no FDA orphan-indication approval yet

  • FDA Imatinib mesylate (Gleevec)Idiopathic Hypereosinophilic Syndrome Chronic eosinophilic leukemia · 2005-08-25

Sources: FDA OOPD · EMA orphan designations

Open Targets candidates

No drugs or clinical candidates returned for this Mondo ID on Open Targets.

CTD chemicals (MyDisease.info)

No CTD chemical associations returned for this Mondo ID.

Literature

Is anyone studying this?

2,235

2,235 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.

2,235 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).

1,012 in the last 10 years · low confidence

Phrase hits: 2,235 · MeSH hits: 1

Open Europe PMC search

Who's working on it?

1,250

Distinct author names in 200 sampled papers — named people below.

Who's working on it?

People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.

  1. 01
    Gotlib J7 papers · 2026

    Division of Hematology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA.

    Papers in Europe PMC
  2. 02
    Reiter A7 papers · 2026

    Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.

    Papers in Europe PMC
  3. 03
    Wang Y5 papers · 2026

    Department of Pathology, Montefiore Medical Center/Albert Einstein College of Medicine, 111 East 210 Street, Bronx 10467, NY, USA.

    Papers in Europe PMC
  4. 04
    Arber DA4 papers · 2025

    Department of Pathology, University of Chicago, IL, Chicago, USA.

    Papers in Europe PMC
  5. 05
    Hasserjian RP4 papers · 2024

    Department of Pathology, Mass General Brigham, Harvard Medical School, Boston, MA, USA. rhasserjian@mgh.harvard.edu.

    Papers in Europe PMC
  6. 06
    Lübke J4 papers · 2026

    Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.

    Papers in Europe PMC
  7. 07
    Metzgeroth G4 papers · 2025

    Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.

    Papers in Europe PMC
  8. 08
    Orazi A4 papers · 2025

    Department of Pathology, Texas Tech University Health Sciences Center, El Paso, TX, USA.

    Papers in Europe PMC
  9. 09
    Schwaab J4 papers · 2025

    Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.

    Papers in Europe PMC
  10. 10
    Chen M3 papers · 2025

    Department of Hematology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, 300381, China.

    Papers in Europe PMC

Clinical research

Is a treatment being tested?

44

interventional trials for this specific condition

44 interventional trials matched this specific condition name; 2 currently recruiting in our sample.

Data as of 11 September 2026

44 interventional trials — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 96.9th percentile).

low confidence · 96.9th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

44 interventional trials matched after quoted-phrase search and title/condition post-filter.

Observational and natural-history studies

3 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.

Recruiting or not-yet-recruiting

Open the complete matched search on ClinicalTrials.gov

Other registries (secondary)

Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.

raw 0 · after dedupe 0 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 0 · dropped 0 · fetched 2026-07-30

Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri

No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).

Where to find support

Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.

Orphanet entry for Chronic eosinophilic leukemia — check Associations / patient organisations on that page.

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

"Chronic eosinophilic leukemia" OR "CEL/hypereosinophilic syndrome" OR "chronic eosinophilic leukemia/hypereosinophilic syndrome" OR "eosinophilic leukaemia" OR "eosinophilic leukemia"

Run this search on Europe PMC

MeSH descriptor terms unioned into the query: Pdgfra-Associated Chronic Eosinophilic Leukemia

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Chronic eosinophilic leukemia" OR "CEL/hypereosinophilic syndrome" OR "chronic eosinophilic leukemia/hypereosinophilic syndrome" OR "eosinophilic leukaemia" OR "eosinophilic leukemia" OR "Pdgfra-Associated Chronic Eosinophilic Leukemia"

Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).

Study-type breakdown: 44 interventional · 3 observational · 0 expanded access. Only interventional studies enter the trial headline.

Query health: ok — strategies attempted: phrase, mesh; with hits: phrase, mesh

Run this search on ClinicalTrials.gov

Synonyms dropped by stoplist: CEL

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • 1 synonym(s) dropped by stoplist (may under-count)
  • No label/synonym collisions with other diseases in this corpus
  • Publication count (2235) is extremely high with unknown/missing prevalence — treat as possible over-matching, not proven research intensity

Ingested 2026-07-27T08:31:47.393Z